Fcme The Journal of Clinical Psychiatry from Physicians Postgraduate Press, Inc
The Journal of Clinical Psychiatry
Ribbon logo

Please take our online poll

Close [X]

Online Poll

Please answer the following questions about treating schizophrenia.

1. Mr A, your 35-year-old patient with schizophrenia, has achieved symptomatic remission, but you notice cognitive problems that might be hindering his progress in social and occupational areas. As you determine treatment goals in these areas, what interview-based assessment should you use to best measure Mr A’s cognitive abilities?

Quality of Life Scale (QLS)

UCSD Performance-Based Skills Assessment (UPSA)

Social Skills Performance Assessment (SSPA)

Schizophrenia Cognition Rating Scale (SCoRS)

2. Based on recent evidence, the most promising treatment target to address positive, negative, and cognitive symptoms of schizophrenia focuses on which of the following neurotransmitters?

mGlu2/3

NMDA

AMPA

Dopamine

Psychiatrist.com
The Journal of Clinical Psychiatry
CME Institute | MedFair.com
The Primary Care Companion

Psychiatrist.com Home          Keyword Search

Close [X]

Search Our Sites

Enter search terms below (keywords, titles, authors, or subjects). Then select a category to search and press the Search button. All words are assumed to be required. To search for an exact phrase, put it in quotes. To exclude a term, precede it with a minus sign (-).

Keyword search:

Choose a category:

Choosing the appropriate category will greatly improve your chances of finding the best match.

All files at our sites: J Clin Psychiatry, Primary Care Companion, CME Institute, and MedFair

Search materials from our journals:

Abstracts from The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements

PDFs of the full text of The Journal of Clinical Psychiatry, 1996–present, both regular issues and supplements (paid subscribers)

PDFs of the full text of The Primary Care Companion, 1999–present

Search CME offerings:

CME Institute, including CME from journals , supplements, and Web activities for instant CME credit (registered users); also includes information about our CME program

CME activities from regular issues of The Journal of Clinical Psychiatry (registered users)

CME Supplements from The Journal of Clinical Psychiatry (registered users)

Psychiatrist.com The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders The CME Institute Neurology Knowledge Terms of Use Privacy Policy

Now @ JCP

Ahead of Print
Current Issue
Forum
Most Popular

Journal Archive

Science, Rhetoric, and the End of Psychosis
Andrew James Amos, MBBS

Dr Amos voices his concerns about bias in the early intervention in psychosis literature. He welcomes your comments.

» Read this post

» Read the entire blog

Schizophrenia: The Role of Dopamine and Glutamate Anissa Abi-Dargham, MD, and Jonathan M. Meyer, MD

New! Learn about dopamine dysfunction in schizophrenia and how glutamate may provide targets for pharmacotherapy.

>>See the entire activity

Residual Symptoms and the Risk of Relapse in Major Depression Michael E. Thase, MD

Discover how residual symptoms increase risk for relapse and how to apply treatment options to achieve asymptomatic remission.

>>See the entire activity

Now @
JCP

Journal
Archive

Collections

Education

Authors &
Reviewers

Ahead of Print
Current Issue
Forums

View full page

Articles published electronically 4/15/14

Gender Differences, Clinical Correlates, and Longitudinal Outcome of Bipolar Disorder With Comorbid Migraine

[Abstract] [Full Text] Posted 4/15/14

Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder: Suicidality Data From Acute and Maintenance Studies

[Abstract] [Full Text] Posted 4/15/14

Effect of Adjunctive l-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype: Results From a Randomized Clinical Trial

[Abstract] [Full Text] Posted 4/15/14

The Alzheimer’s Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer’s Disease Treatments in Presenilin 1 E280A Mutation Carriers

[Abstract] [Full Text] Posted 4/15/14

Articles published electronically 3/31/14

Physical Activity Interventions for People With Mental Illness: A Systematic Review and Meta-Analysis

[Abstract] [Full Text] Posted 3/31/14

Articles published electronically 3/7/14

Schizophrenia: Mechanism of Action of Current and Novel Treatments [CME]

[Full Text] [CME Posttest] Posted 3/7/14

Articles published electronically 2/18/14

Agomelatine in Generalized Anxiety Disorder: An Active Comparator and Placebo-Controlled Study

[Abstract] [Full Text] Posted 2/18/14

Articles published electronically 2/4/14

Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data

[Abstract] [Full Text] Posted 2/4/14

The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale

[Abstract] [Full Text] Posted 2/4/14

Articles published electronically 1/21/14

The Relationship Between Affective State and the Rhythmicity of Activity in Bipolar Disorder

[Abstract] [Full Text] Posted 1/21/14

The Relationship Between Bipolar Disorder and Biological Rhythms

[Abstract] [Full Text] Posted 1/21/14

An Exploratory Randomized Controlled Study of a Healthy Living Intervention in Early Intervention Services for Psychosis: the INTERvention to Encourage ACTivity, Improve Diet, and Reduce Weight Gain (INTERACT) Study

[Abstract] [Full Text] Posted 1/21/14

Urinary Tract Infections in Acute Psychosis

[Abstract] [Full Text] Posted 1/21/14

Articles published electronically 1/7/14

National Trends in Second-Generation Antipsychotic Augmentation for Nonpsychotic Depression

[Abstract] [Full Text] Posted 1/7/14

The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

[Abstract] [Full Text] Posted 1/7/14

Articles published electronically 12/24/13

A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

[Abstract] [Full Text] Posted 12/24/13

Articles published electronically 12/10/13

A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers

[Abstract] [Full Text] Posted 12/10/13

Ahead of Print
Current Issue
Forums

View full page

Volume 75April 2014Number 4

 

CME Commentary

348 Posttest

 

347 Schizophrenia: Mechanism of Action of Current and Novel Treatments [Free Access]

CME Background

CME Article

356 Posttest

 

349 The Impact of Cannabis and Stimulant Disorders on Diagnostic Stability in Psychosis

Original Research

336 A Randomized Trial of Concurrent Smoking-Cessation and Substance Use Disorder Treatment in Stimulant-Dependent Smokers

357 The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study

362 Agomelatine in Generalized Anxiety Disorder: An Active Comparator and Placebo-Controlled Study

370 A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder

Early Career Psychiatrists

377 The Changing Landscape of Psychiatry

379 Urinary Tract Infections in Acute Psychosis

386 Attention-Deficit/Hyperactivity Disorder Symptom Expression: A Comparison of Individual Age at Onset Using Item Response Theory

393 The Mental Health Characteristics of Pregnant Women With Depressive Symptoms Identified by the Edinburgh Postnatal Depression Scale

399 Relationship Between Acculturation, Discrimination, and Suicidal Ideation and Attempts Among US Hispanics in the National Epidemiologic Survey of Alcohol and Related Conditions

Letter to the Editor

408 Climate and Prevalence of Mood Disorders: A Cross-National Correlation Study

Online Exclusives

Practical Psychopharmacology

e292 Potentially Significant Versus Clinically Significant Drug Interactions: Pomegranate Juice as a Case in Point

Review Article

e294 Translating Molecular Advances in Fragile X Syndrome Into Therapy: A Review

Original Research

e308 Determinants of Antipsychotic Response in Schizophrenia: Implications for Practice and Future Clinical Trials

Early Career Psychiatrists

e317 The Relationship Between Affective State and the Rhythmicity of Activity in Bipolar Disorder

e323 The Relationship Between Bipolar Disorder and Biological Rhythms [Review]

Book Review

e332 Practical Neurology, 4th ed

Online Activities

e08 Latest Guidelines and Advances for Treatment of Restless Legs Syndrome [CME]

e09 Recognizing Primary Vs Secondary Negative Symptoms and Apathy Vs Expression Domains [CME]

e10 Acute and Maintenance Treatments for Bipolar Depression [CME]

Information for Authors

see www.psychiatrist.com/author.htm

Supplements|Buy a Single Article|Most Popular

The Journal of Clinical Psychiatry is the official journal of the American Society for Clinical Psychopharmacology

JCP Online ForumsJCP Online Forum

View full page

Join the Discussion

Potentially Significant Versus Clinically Significant Drug Interactions: Pomegranate Juice as a Case in Point Chittaranjan Andrade
[Full Text With Comments]

Antidepressants and Testicular Cancer: Cause Versus Association Chittaranjan Andrade
[Full Text With Comments]

Selective Serotonin Reuptake Inhibitor Drug Interactions in Patients Receiving Statins Chittaranjan Andrade
[Full Text With Comments]

Augmenting Selective Serotonin Reuptake Inhibitors With Clomipramine in Obsessive-Compulsive Disorder: Benefits and Risks Chittaranjan Andrade
[Full Text With Comments]

Learning From History: How to Swallow a Pill Chittaranjan Andrade
[Full Text With Comments]

Famotidine Augmentation in Schizophrenia: Hope or Hype? Chittaranjan Andrade
[Full Text With Comments]

Levothyroxine in Psychiatry: Issues Related to Absorption After Oral Dosing Chittaranjan Andrade
[Full Text With Comments]

Antenatal Exposure to Selective Serotonin Reuptake Inhibitors and Duration of Gestation Chittaranjan Andrade
[Full Text With Comments]

Low-Dose Amisulpride and Elevation in Serum Prolactin Chittaranjan Andrade
[Full Text With Comments]

Signal-to-Noise Ratio, Variability, and Their Relevance in Clinical Trials Chittaranjan Andrade
[Full Text With Comments]

Lessons Learned From d-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy Thomas L. Rodebaugh and Eric J. Lenze
[Full Text With Comments]

Antidepressant Action of Atypical Antipsychotics: Focus on Ziprasidone Monotherapy, With a Few Twists in the Tale Chittaranjan Andrade
[Full Text With Comments]

Augmentation of Venlafaxine With Bupropion: Risks Associated With a Triple Monoamine Reuptake Inhibition Approach to Partially Responsive Depression Chittaranjan Andrade
[Full Text With Comments]

Drug Interactions in the Treatment of Depression in Patients Receiving β-Blocker Drugs Chittaranjan Andrade
[Full Text With Comments]

Drug Interactions in the Treatment of Depression in Patients With Ischemic Heart Disease Chittaranjan Andrade
[Full Text With Comments]

Serotonin Reuptake Inhibitor Treatment of Obsessive-Compulsive Symptoms in Clozapine-Medicated Schizophrenia Chittaranjan Andrade
[Full Text With Comments]

There’s More to Placebo-Related Improvement Than the Placebo Effect Alone Chittaranjan Andrade
[Full Text With Comments]

Breast Cancer and Antidepressant Use Chittaranjan Andrade
[Full Text With Comments]

Modafinil and Armodafinil in Schizophrenia Chittaranjan Andrade
[Full Text With Comments]

Drugs That Escape Hepatic Metabolism Chittaranjan Andrade
[Full Text With Comments]

Practical Psychopharmacology: Schizophrenia and Smoking Chittaranjan Andrade
[Full Text With Comments]

Practical Psychopharmacology: Selective Serotonin Reuptake Inhibitors and Persistent Pulmonary Hypertension of the Newborn Chittaranjan Andrade
[Full Text With Comments]

Commentary: Depression in Women: Windows of Vulnerability and New Insights Into the Link Between Estrogen and Serotonin Sonali Lokuge, Benicio N. Frey, Jane A. Foster, Claudio N. Soares, and Meir Steiner
[Full Text With Comments]

Does DSM-IV Already Capture the Dimensional Nature of Personality Disorders? Mark Zimmerman, Iwona Chelminski, Diane Young, Kristy Dalrymple and Jennifer Martinez
[Full Text With Comments]

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It Leonard J. Paulozzi, Richard H. Weisler, and Ashwin A. Patkar
[Full Text With Comments]

Editors’ Perspectives: Peer Review and the Evolving Journal

Commentaries on Peer Review and the Evolving Journal. Marlene P. Freeman
[Full Text With Forum]

Peer Review Perspective for Early Career Psychiatrists. Alan J. Gelenberg
[Full Text With Forum]

Learning to Review. Robert Freedman
[Full Text With Forum]

Peer Review by Early Career Psychiatrists: An Opportunity for Development. Anne F. Gross, Ilse R. Wiechers, and Theodore A. Stern
[Full Text With Forum]

The Evolution of the Psychiatry Research Journal. John H. Krystal
[Full Text With Forum]

Peer Review in Early Career: Just Say Yes! Peter P. Roy-Byrne
[Full Text With Forum]

Perspectives on Perinatal Depression Treatment

Perinatal Psychiatry: The Challenges of Making Rational Treatment Decisions at the Interface of Psychiatry and Obstetrics. Marlene P. Freeman
[Full Text With Forum]

Influence of the Media on Women Taking Antidepressants During Pregnancy. Adrienne Einarson
[Full Text With Forum]

The Other Side of the Risk Equation: Exploring Risks of Untreated Depression and Anxiety in Pregnancy. Ellen M. Markus and Laura J. Miller
[Full Text With Forum]

Reflections on Perinatal Depression Treatment. Bryanne Barnett, and Marie-Paule Austin
[Full Text With Forum]

Do We Scare Because We Care? Diane N. Solomon
[Full Text With Forum]

Perinatal Depression: Searching for Specific Tools for a Closer Look at This Window. Claudio N. Soares, and Meir Steiner
[Full Text With Forum]

Psychotherapeutic Treatment Options for Perinatal Depression: Emphasis on Maternal-Infant Dyadic Outcomes. Maria Muzik, Sheila M. Marcus, and Heather A. Flynn
[Full Text With Forum]

No Decision Is Without Risk. Rita Suri, and Lori L. Altshuler
[Full Text With Forum]

The Cost of Restricting Knowledge. Anna R. Brandon, Geetha Shivakumar, Stephen J. Inrig, Simon J. Craddock Lee, and John Z. Sadler
[Full Text With Forum]

Pharmacotherapy or Untreated Antenatal Depression: A False Dichotomy. Sona Dimidjian, and Michael W. O’Hara
[Full Text With Forum]

 

Online Journal Offerings

| 2014 | 2013 | 2012 | 2011 | 2010 |

| 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 |

| 1999 | 1998 | 1997 | 1996 |

Switching Antipsychotic Medications to Reduce Adverse Event Burden in Schizophrenia: Establishing Evidence-Based Practice

John W. Newcomer, Peter J. Weiden, and Robert W. Buchanan

Read this Academic Highlights to receive evidence-based guidance concerning when and how it is appropriate to undertake elective changes in antipsychotic medications in order to reduce adverse effects, particularly those associated with increased long-term health risks.

>>See the entire activity

>>See all available Academic Highlights

Measurement-Based Strategies to Assess and Manage Schizophrenia

Leslie Citrome, MD, MPH (Chair), et al

In this Supplement, discover how to distinguish between primary and secondary negative symptoms, find out how to assess treatment response and functioning, and review new therapeutic targets in the treatment of schizophrenia.

>>See the entire supplement

>>See all available supplements

CME

Outcomes in Bipolar Patients

Christian Simhandl, MD, PhD (Chair), et al

Two-thirds of patients with bipolar disorder relapsed during a 4-year, naturalistic follow-up. The variable with the most protective effect against relapse was that patients not stop or change medication. Explore these and other findings in this CME article.

>>See the entire activity

>>See all Journal CME activities

Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say?

Susan L. McElroy, MD

Find out why antidepressant monotherapy is not recommended by current guidelines, what risks are associated with their use, and when their use is indicated.

>>See the entire activity

>>See all Multimedia activities

Clinical and Cost Implications of Treating Schizophrenia

John M. Kane, MD (Chair), et al

Read this PEARL 3 InfoPack to explore strategies to enhance cognition in your patients with schizophrenia. Plus, learn about effects of short- and long-term antipsychotics and costs associated with treatment.

>>See the entire activity

>>See all Special Features

Learn. Practice. Treat.

Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

Eduard Vieta, PhD

Review existing medications and learn about new treatments for bipolar depression to help your patients achieve remission.

>>See the entire activity

>>See related activities

Printer-friendly version

Manuscript and Letter Submission

Submit a Manuscript Now

If your manuscript fits within the scope of the journal, we encourage you to submit. Acceptance is contingent on favorable peer review.

Our user-friendly electronic manuscript submission and peer review system allows you to submit your manuscript online securely, conveniently, and instantly. Authors can track the progress of their manuscripts from submission to publication. Assistance is available via e-mail if needed.

First-time submitters will need to register for an account. After you follow the link above for the submission page, select “New authors should register for an account.” Note that this account is separate from the account you use to access Psychiatrist.com and CMEInstitute.com, so even if you are already registered to access our sites (which provides the ability to obtain free CME credit), you will still need to establish an account to use the manuscript submission system.

Journal Statistics and Impact Information

Journal Statistics (2013 Data)

Acceptance rate

 

28%

No. of articles published per issue

 

Mean=10

Submission-to–first decision time (mean)

 

47 days

Submission-to–final decision time (mean)

 

66 days

Submission-to-acceptance time (estimated average)

 

4.8 months

Acceptance-to-publication time

 

4.9 months

Impact Information

The Journal of Clinical Psychiatry continues to be ranked in the top ten of the most cited psychiatric journals in the world—and as the #1 clinical psychiatry journal—with an IF of 5.799. Moreover, the Journal is ranked as the world’s fourth most important psychiatric journal, with an Eigenfactor™ score of 0.03655 (December 2011, Journal Citation Reports). The Journal mails to about 34,690 recipients, and over 20,000 allied mental health professionals have requested daily receipt of informational e-mails about our journals and Web CME activities.

The Journal of Clinical Psychiatry is the official journal of the American Society of Clinical Psychopharmacology. The ASCP was founded in 1992, and its membership includes clinicians and researchers who study the use of pharmacology in clinical practice.

Free Access Option

The Journal of Clinical Psychiatry (JCP) offers authors of accepted articles and letters the opportunity to make their article freely available to nonsubscribers on JCP’s Web site, PSYCHIATRIST.COM. The charge for this service is $2,500 and is payable by check or credit card. Authors are provided this option at the time of acceptance.

Your article reaches 36,000 readers of the print journal, but the JCP Web site attracts over 200,000 visitors each month, most of whom are nonsubscribers who must pay a fee to read an entire article online. The option of financial sponsorship allows you to provide each Web visitor unrestricted access to your HTML article, thereby increasing its potential audience nearly sixfold. To further expand your article’s visibility, an e-mail announcement of its Free status will be sent to over 35,000 JCP E-Lert requestors.

Submission of payment signifies your agreement to the Terms and Conditions for copyrighted work.

Authorship / Copyright / Disclosure / Acknowledgment Form

See the form in PDF format. At the time of article submission, each author must submit a form incorporating 4 statements: (1) authorship, (2) copyright transfer or federal employment, and (3) financial or other relationships that might pose a conflict of interest. The corresponding author must sign (4) the Acknowledgment statement. This form can be mailed to Physicians Postgraduate Press, P.O. Box 752870, Memphis, TN 38175-2870, faxed to the Production Coordinator at 901-273-2752, or scanned and uploaded during the electronic submission process.

Quick-Reference Checklist for Manuscript Submission

See the checklist.

Guidelines for Authors on Manuscript Preparation and Submission

See the guidelines.

Reprints

Corresponding authors receive a complimentary copy of the issue in which their article or letter appears and are sent a reprint order form at the time their article is published. Authors can also order single copies of articles or back issues, as well as larger quantities of high-quality photocopies or reprints. Learn more about reprints.

Terms and Conditions

All materials published by Physicians Postgraduate Press, Inc., are the property of Physicians Postgraduate Press, Inc., unless otherwise stated, and are subject to all laws pertaining to copyrighted work.

Retention of copyright by Physicians Postgraduate Press, Inc., means the work may not be reproduced or transmitted in any form or by any means, including electronic, photocopying, or otherwise; distributed in any form or by any means; publicly displayed in any form including but not limited to internet, extranet, PowerPoint, or posters; and used for commercial, promotional, or marketing purposes, which include sale, resale, transfer, loan, license, or other forms of commercial exploitation.

Reprints

Entire reprints may be purchased from reprints@psychiatrist.com.

Permissions

For permission to use the work in whole or part, follow these steps:

  1. Requests for permission to publish may be submitted by regular mail, fax, or e-mail.
    • Physicians Postgraduate Press, Inc.
      Attn: Permissions Editor
      850 Ridge Lake Blvd, Suite 300
      Memphis, TN 38120
      fax: (920) 457-0501
      e-mail: permissions@psychiatrist.com
  2. Permission will not be granted until the article has been published in The Journal of Clinical Psychiatry or The Primary Care Companion for CNS Disorders.
  3. Permission is not granted to place the full text of The Journal of Clinical Psychiatry or The Primary Care Companion for CNS Disorders articles on other Web sites.

Information Required for a Permissions Request

  1. Requestor’s Information:
    • Person’s name, title, address, telephone, fax, and e-mail
    • Company’s name and postal address
  2. Article Information:
    • Article title
    • First bylined author
    • Volume number and issue dates
    • Page range of article
    • The copyrighted item to be used from the article, ie, the specific chart, table, figure, graph, or other illustration, abstract, quote, or full article
  3. Intended Use of the Requested Item:
    • Title of the work in which the item is to appear
    • Author/editor/compiler
    • Publisher, with full address
    • Edition number
    • Publication year
    • Approximate press run of work
    • Form of reproduction (print, online, language)
    • Sponsorship, funding, or retail price (if a book)
    • Intended audience(s)

Clinical Trials Registration Information

See the clinical trials registration information in our Guidelines for Authors on Manuscript Preparation and Submission.

Embargo Policy

Articles are embargoed until they are published online at PSYCHIATRIST.COM. Contact .

Helpful Links

 

Printer-friendly version

Manuscripts that meet the Journal’s scope and submission criteria are sent to expert consultants for peer review.

Conflict of Interest

Reviewers who have a financial or personal conflict of interest related to a manuscript are obligated to decline the reviewer position.

Processing of Peer Reviews

The peer review process is conducted using the electronic submission system used for manuscripts. Potential reviewers are queried in advance about their availability. While reviewers are asked to complete their reviews within 3 weeks of receiving the manuscript, more expeditious turnaround is highly valued. If you would like to be a peer reviewer, please send your CV to .

Confidentiality

The reviewers' identities are not revealed, and strict confidentiality regarding the submitted manuscript is maintained. Reviewers must not keep copies of the manuscripts they review or discuss any of the information or data with others.

Circle of Honor

Peer review is essential to a medical journal, and each year, those peer reviewers who have carried the heaviest load and reviewed the greatest number of manuscripts are recognized as members of the Journal’s Circle of Honor.

The Circle of Honor is the Journal’s acknowledgment of the indispensable contribution—the dedication, scholarship, and scientific rigor—generously donated by these individuals.

2013 Circle of Honor

Chittaranjan Andrade, MD

Scott A. Freeman, MD

Jerry L. Halverson, MD

Ahmad Hameed, MD

James W. Jefferson, MD

James H. Kocsis, MD

Susan G. Kornstein, MD

Mario Maj, MD

John C. Markowitz, MD

Susan L. McElroy, MD

Roger E. Meyer, MD

J. Craig Nelson, MD

Michael K. Popkin, MD

Jerrold F. Rosenbaum, MD

Barbara O. Rothbaum, PhD

Erika F. H. Saunders, MD

Mauricio Tohen, MD, DrPH

Mark Zimmerman, MD

Authors and Reviewers

Information for Authors
Information for Reviewers

Terms of Use | Privacy Policy | See Full Website
© Copyright 2010 Physicians Postgraduate Press, Inc.
MedFair.com US Patent No. 6847940